abstract |
The present invention focuses on DNA vaccines in APCs that are mediated by targeting IgE receptors (FcεR) on antigen presenting cells (APCs) and providing regulatory elements specific for APCs to promote DNA expression And a novel approach to develop. The present invention provides novel vaccines for concentrating and expressing DNA, and methods of using such compounds, compositions, and products containing them. This vaccine can be used for prevention or treatment of allergic diseases. |